RepliCel Life Sciences Inc. RepliCel Life Sciences Inc.

RepliCel Life Sciences Inc.

RP

株式のランク #38677
Headquartered in Vancouver, Canada, RepliCel Life Sciences Inc. is a... Headquartered in Vancouver, Canada, RepliCel Life Sciences Inc. is a regenerative medicine company dedicated to developing innovative autologous cell therapies. These treatments are designed to correct functional cellular deficiencies by harnessing a patient's own cells. The process involves isolating cells from harvested tissues, significantly expanding them in a controlled laboratory environment, and subsequently applying them therapeutically. The company's developmental portfolio includes several key product candidates: RCT-01 targets chronic tendinosis, RCS-01 addresses aging and sun-damaged skin, and RCH-01 is aimed at treating hair loss. Additionally, RepliCel is advancing RCI-02, a specialized dermal injection device. RepliCel has established significant strategic alliances. It holds a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. to establish a clinical research program and facilitate the commercialization of RCS-01 and RCT-01. A similar collaboration exists with Shiseido Company, Limited, focusing on the clinical research program for RCH-01. Furthermore, the company is engaged in a research project agreement with the University of British Columbia, contributing to the creation of a comprehensive hair follicle cell data map.
株価
$0.01100905
最終同期: 2025-02-28
時価総額
$810.02K
変化(1日)
58.98%
変化(1年)
10,909.05%
国
CA
取引 RepliCel Life Sciences Inc. (RP)

カテゴリー

Healthcare
RepliCel Life Sciences Inc.(RP)の株価履歴
終値の最高値: $0.00 (2026-10-01)

終値の最安値: $0.16 (2010-05-01)
RepliCel Life Sciences Inc. の株価履歴(2010 ~ 2026)
年間株価パフォーマンス
年 パフォーマンス
2026 (TTM) 0.00%
2025 -95.09%
2024 -63.87%
2023 -25.97%
2022 -62.91%
2021 19.36%
2020 -9.55%
2019 -29.32%
2018 -23.47%
2017 -44.02%
2016 -66.76%
2015 -35.40%
2014 -42.41%
2013 -10.99%
2012 -75.85%
2011 47.04%
2010 0.00%
類似企業または競合の株価
企業 株価 変化率 1年% 国
$516.85 21.25%
US
$247.28 799.51%
US
$138.33 -3.31%
AU
$882.70 5.74%
NL
$753.36 7.47%
CH